As of April 16, 2025, Monte Rosa Therapeutics (GLUE) has a market cap of $0.27 billion USD. According to our data, Monte Rosa Therapeutics is ranked No.6620 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.27 B |
-36.09%
|
Dec 31, 2024 | $0.43 B |
22.83%
|
Dec 29, 2023 | $0.35 B |
-25.76%
|
Dec 30, 2022 | $0.47 B |
-62.73%
|
Dec 31, 2021 | $1.25 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Arvinas
ARVN
|
$0.52 B |
0.000 M
|
![]() USA
|
![]() Kymera Therapeutics
KYMR
|
$1.65 B |
0.000 M
|
![]() USA
|
![]() C4 Therapeutics
CCCC
|
$84.48 M |
0.000 M
|
![]() USA
|
![]() Nurix Therapeutics
NRIX
|
$0.75 B |
0.000 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$6.75 B |
0.000 M
|
![]() USA
|
![]() Zentalis Pharmaceuticals
ZNTL
|
$91.20 M |
0.000 M
|
![]() USA
|
![]() Kronos Bio
KRON
|
$52.92 M |
0.000 M
|
![]() USA
|
![]() Tango Therapeutics
TNGX
|
$0.15 B |
-0.000 M
|
![]() USA
|
![]() Foghorn Therapeutics
FHTX
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() Erasca
ERAS
|
$0.34 B |
-0.000 M
|
![]() USA
|
![]() Olema Pharmaceuticals
OLMA
|
$0.29 B |
-0.000 M
|
![]() USA
|
![]() PMV Pharmaceuticals
PMVP
|
$54.01 M |
0.000 M
|
![]() USA
|
Market Cap | = | GLUE Stock Price | * | GLUE Shares Outstanding |
= | $4.43 | * | 61.51 M | |
= | $0.27 B |